Skip to main content
Top
Published in: Psychiatric Quarterly 3/2007

01-09-2007 | Original Paper

Assessing Obesity and Other Related Health Problems of Mentally Ill Hispanic Patients in an Urban Outpatient Setting

Authors: David J. Hellerstein, M.D., Goretti Almeida, M.B.A, Michael J. Devlin, M.D., Nathaniel Mendelsohn, A.B., Stacia Helfand, M.Ed., Dianna Dragatsi, M.D., Raquel Miranda, R.N., Julie R. Kelso, M.D., Lucia Capitelli, R.N.

Published in: Psychiatric Quarterly | Issue 3/2007

Login to get access

Abstract

Objective

This paper describes the role of an agency Clinical Director in developing a project to assess and begin to address obesity-related health problems of patients treated in a community-based mental health clinic in New York City. After a five year review of outpatient deaths revealed a high rate of deaths from cardiovascular and diabetes-related issues, the Clinical Director assembled a group of clinicians, researchers, and administrative staff to design a pilot project to assess health and nutrition status of primarily Hispanic day treatment patients with severe and persistent mental illness.

Method

About 69 of the 105 patients at the clinic were assessed by chart review, interview about nutritional habits and medical care, and somatic measurements for blood pressure, weight, girth, body mass index (BMI), glucose and lipid levels.

Results

Patients were predominantly between the ages of 25 and 64 years, 51% were female, and 78% were Hispanic. Around 57% were diagnosed with schizophrenia-spectrum disorders, 86% were receiving antipsychotic medications, and 25% were on two or more antipsychotics. Only 11% of the women and 41% of the men had normal weight. A total of 29% of the women and 18% of the men were overweight (BMI = 25–29.9); and an additional 60% of the women and 41% of the men were obese (BMI ≥ 30). Atypical antipsychotic treatment was significantly associated with obesity (BMI ≥ 30) (chi sq = 5.5, df = 1, P < 0.025). Using American Heart Association criteria, waist measurements showed significant abdominal obesity among female patients. Blood pressure was elevated in 77% of the patients: 45% were pre-hypertensive with BP 120–139/80–89 and 32% were hypertensive with BP ≥ 140/90. About 53% had elevated random blood glucoses (>110 mg/dl). On the positive side, patients generally had had recent medical follow-up, and most had adequate cooking facilities.

Conclusions

This project revealed that these predominantly Hispanic, severely mentally ill individuals were at high risk for cardiac illness, highlighting the need for developing culturally-sensitive interventions in urban outpatient psychiatric settings. Findings were disseminated in educational presentations and clinical discussions, and have mobilized an institutional effort to significantly improve medical monitoring for these patients.
Literature
1.
go back to reference Moktad AH, Ford ES, Bowman BA, et al.: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association 289:76–79, 2003.CrossRef Moktad AH, Ford ES, Bowman BA, et al.: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association 289:76–79, 2003.CrossRef
2.
go back to reference Marder SR, Essock SM, Miller AL, et al.: Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 161:1334–1349, 2004.PubMedCrossRef Marder SR, Essock SM, Miller AL, et al.: Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 161:1334–1349, 2004.PubMedCrossRef
3.
go back to reference Allison DB, Fontaine DR, Heo M, et al.: The distribution of body mass index among individuals with and without schizophrenia. Journal of Clinical Psychiatry 60:215–220, 1999.PubMedCrossRef Allison DB, Fontaine DR, Heo M, et al.: The distribution of body mass index among individuals with and without schizophrenia. Journal of Clinical Psychiatry 60:215–220, 1999.PubMedCrossRef
4.
go back to reference McElroy SL, Frye MA, Suppes T, et al.: Correlates of overweight and obesity in 644 patients with bipolar disorder. Journal of Clinical Psychiatry 63:201–213, 2002. McElroy SL, Frye MA, Suppes T, et al.: Correlates of overweight and obesity in 644 patients with bipolar disorder. Journal of Clinical Psychiatry 63:201–213, 2002.
5.
go back to reference Dalak GW, Healy DJ, Meador-Woodruff JH: Nicotine dependence in schizophrenia: A clinical phenomena and laboratory findings. American Journal of Psychiatry 155:1490–1501, 1998. Dalak GW, Healy DJ, Meador-Woodruff JH: Nicotine dependence in schizophrenia: A clinical phenomena and laboratory findings. American Journal of Psychiatry 155:1490–1501, 1998.
6.
go back to reference Allison DB, Mentore JL, Heo M, et al.: Antipsychotic-induced weight gain; a comprehensive research synthesis. American Journal of Psychiatry 156:1686–1696, 1999.PubMed Allison DB, Mentore JL, Heo M, et al.: Antipsychotic-induced weight gain; a comprehensive research synthesis. American Journal of Psychiatry 156:1686–1696, 1999.PubMed
7.
go back to reference Virk S, Schwartz TL, Jindal S, et al.: Psychiatric medication induced obesity: An aetiologic review. Obesity Reviews 5:167–170, 2004.PubMedCrossRef Virk S, Schwartz TL, Jindal S, et al.: Psychiatric medication induced obesity: An aetiologic review. Obesity Reviews 5:167–170, 2004.PubMedCrossRef
8.
go back to reference Nasrallah H: A review of the effect of atypical antipsychotics on weight. Psychoneuroendocinology 28(suppl 1):83–86, 2003.CrossRef Nasrallah H: A review of the effect of atypical antipsychotics on weight. Psychoneuroendocinology 28(suppl 1):83–86, 2003.CrossRef
9.
go back to reference Blackburn GL: Weight gain and antipsychotic medication. Journal of Clinical Psychiatry 61(suppl 8):36–41, 2000.PubMed Blackburn GL: Weight gain and antipsychotic medication. Journal of Clinical Psychiatry 61(suppl 8):36–41, 2000.PubMed
10.
go back to reference Wirshing DA, Wirshing WC, Kysar L, et al.: Novel antipsychotics: Comparison of weight gain liabilities. Journal of Clinical Psychiatry 158:765–774; correction 158:1759, 2001. Wirshing DA, Wirshing WC, Kysar L, et al.: Novel antipsychotics: Comparison of weight gain liabilities. Journal of Clinical Psychiatry 158:765–774; correction 158:1759, 2001.
11.
go back to reference Bustillo JR, Buchanan RW, Irish D, et al.: Differential effect of clozapine on weight: A controlled study. American Journal of Psychiatry 153:817–819, 1996.PubMed Bustillo JR, Buchanan RW, Irish D, et al.: Differential effect of clozapine on weight: A controlled study. American Journal of Psychiatry 153:817–819, 1996.PubMed
12.
go back to reference Vanina Y, Podolska A, Sedky K, et al.: Body weight changes associated with psychopharmacology. Psychiatric Services 53:842–847, 2002.PubMedCrossRef Vanina Y, Podolska A, Sedky K, et al.: Body weight changes associated with psychopharmacology. Psychiatric Services 53:842–847, 2002.PubMedCrossRef
13.
go back to reference Jones LE, Clarke W, Carney CP: Receipt of diabetes services by insured adults with and without claims for mental disorders. Medical Care 42:1167–1175, 2004.PubMedCrossRef Jones LE, Clarke W, Carney CP: Receipt of diabetes services by insured adults with and without claims for mental disorders. Medical Care 42:1167–1175, 2004.PubMedCrossRef
14.
go back to reference Homel P, Casey D, Allison DB: Changes in body mass index for individuals with and without schizophrenia, 1987–1996. Schizophrenia Research 55:277–284, 2002.PubMedCrossRef Homel P, Casey D, Allison DB: Changes in body mass index for individuals with and without schizophrenia, 1987–1996. Schizophrenia Research 55:277–284, 2002.PubMedCrossRef
15.
go back to reference Ganguli R, Brar JS, Ayrton Z: Weight gain over 4 months in schizophrenia patients: A comparison of olanzapine and risperidone. Schizophrenia Research 49:261–267, 2001.PubMedCrossRef Ganguli R, Brar JS, Ayrton Z: Weight gain over 4 months in schizophrenia patients: A comparison of olanzapine and risperidone. Schizophrenia Research 49:261–267, 2001.PubMedCrossRef
16.
go back to reference Basson BR, Kinon BJ, Taylor CC, et al.: Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. Journal of Clinical Psychiatry 62:231–238, 2001.PubMedCrossRef Basson BR, Kinon BJ, Taylor CC, et al.: Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. Journal of Clinical Psychiatry 62:231–238, 2001.PubMedCrossRef
17.
go back to reference Bustillo JR, Buchanan RW, Irish D, et al.: Differential effect of clozapine on weight: A controlled study. American Journal of Psychiatry 153:817–819, 1996.PubMed Bustillo JR, Buchanan RW, Irish D, et al.: Differential effect of clozapine on weight: A controlled study. American Journal of Psychiatry 153:817–819, 1996.PubMed
18.
go back to reference Elmslie JL, Silverstone JT, Mann JL, et al.: Prevalence of overweight and obesity in bipolar patients. Journal of Clinical Psychiatry 61:179–184, 2000.PubMedCrossRef Elmslie JL, Silverstone JT, Mann JL, et al.: Prevalence of overweight and obesity in bipolar patients. Journal of Clinical Psychiatry 61:179–184, 2000.PubMedCrossRef
19.
go back to reference Lieberman JA, Stroup TS, McEvoy JP, et al, the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators: Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. New England Journal of Medicine 353:1209–1223, 2005.PubMedCrossRef Lieberman JA, Stroup TS, McEvoy JP, et al, the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators: Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. New England Journal of Medicine 353:1209–1223, 2005.PubMedCrossRef
20.
go back to reference Martinez JA, Velasco JJ, Urbistondo MD: Effects of pharmacological therapy on anthropometric and biochemical status of male and female institutionalized psychiatric patients. Journal of the American College of Nutrition 13:192–197, 1994.PubMed Martinez JA, Velasco JJ, Urbistondo MD: Effects of pharmacological therapy on anthropometric and biochemical status of male and female institutionalized psychiatric patients. Journal of the American College of Nutrition 13:192–197, 1994.PubMed
21.
go back to reference Susce MT, Villanueva N, Diaz FJ, et al.: Obesity and associated complications in patients with severe mental illnesses: A cross-sectional survey. Journal of Clinical Psychiatry 66:167–173, 2005.PubMedCrossRef Susce MT, Villanueva N, Diaz FJ, et al.: Obesity and associated complications in patients with severe mental illnesses: A cross-sectional survey. Journal of Clinical Psychiatry 66:167–173, 2005.PubMedCrossRef
22.
go back to reference Grundy SM, Brewer HB, Cleeman JI, et al.: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109:433–438, 2004.PubMedCrossRef Grundy SM, Brewer HB, Cleeman JI, et al.: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109:433–438, 2004.PubMedCrossRef
23.
go back to reference Yusuf S, Hawken S, Ounpuu S, et al.: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364:937–52, 2004.PubMedCrossRef Yusuf S, Hawken S, Ounpuu S, et al.: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364:937–52, 2004.PubMedCrossRef
24.
go back to reference Yusuf S, Hawken S, Ôunpuu S, et al.: Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: A case-control study. Lancet 366:1640–1649, 2005.PubMedCrossRef Yusuf S, Hawken S, Ôunpuu S, et al.: Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: A case-control study. Lancet 366:1640–1649, 2005.PubMedCrossRef
25.
go back to reference Meyer J, Koro CE, L’Italien GJ: The metabolic syndrome and schizophrenia: A review. International Journal of Psychiatry 17:173–180, 2005.CrossRef Meyer J, Koro CE, L’Italien GJ: The metabolic syndrome and schizophrenia: A review. International Journal of Psychiatry 17:173–180, 2005.CrossRef
26.
go back to reference Gracious BL, Meyer AE: Psychotropic-induced weight gain and potential pharmacologic treatment strategies. Psychiatry 2005; 36–42, 2005. Gracious BL, Meyer AE: Psychotropic-induced weight gain and potential pharmacologic treatment strategies. Psychiatry 2005; 36–42, 2005.
27.
go back to reference Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 285:2486–2497, 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 285:2486–2497, 2001.
28.
go back to reference Flegal KM, Carroll MD, Ogden CL, et al.: Prevalence and trends in obesity among U.S. adults, 1999–2000. Journal of the American Medical Association 288:1723–1727, 2002.PubMedCrossRef Flegal KM, Carroll MD, Ogden CL, et al.: Prevalence and trends in obesity among U.S. adults, 1999–2000. Journal of the American Medical Association 288:1723–1727, 2002.PubMedCrossRef
29.
go back to reference Khan LK, Sobal J, Martorell R: Acculturation, socioeconomic status, and obesity in Mexican Americans, Cuban Americans, and Puerto Ricans. International Journal of Obesity 21:91–96, 1997.PubMedCrossRef Khan LK, Sobal J, Martorell R: Acculturation, socioeconomic status, and obesity in Mexican Americans, Cuban Americans, and Puerto Ricans. International Journal of Obesity 21:91–96, 1997.PubMedCrossRef
30.
go back to reference Lin H, Bermudez OI, Tucker KL: Dietary patterns of Hispanic elders are associated with acculturation and obesity. Journal of Nutrition 133:3651–3657, 2003.PubMed Lin H, Bermudez OI, Tucker KL: Dietary patterns of Hispanic elders are associated with acculturation and obesity. Journal of Nutrition 133:3651–3657, 2003.PubMed
31.
go back to reference Brar JS, Ganguli R, Pandina G, et al.: Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry 66:205–212, 2005.PubMed Brar JS, Ganguli R, Pandina G, et al.: Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry 66:205–212, 2005.PubMed
32.
go back to reference Ranz J, McQuistion HL, Stueve A: The role of the community psychiatrist as medical director: A delineation of job types. Psychiatric Services 51:930–932, 2000.PubMedCrossRef Ranz J, McQuistion HL, Stueve A: The role of the community psychiatrist as medical director: A delineation of job types. Psychiatric Services 51:930–932, 2000.PubMedCrossRef
33.
go back to reference Davidoff F, Batalden P: Toward stronger evidence on quality improvement. Draft publication guidelines: The beginning of a consensus project. Quality and Safety in Health Care 14:319–325, 2005.PubMedCrossRef Davidoff F, Batalden P: Toward stronger evidence on quality improvement. Draft publication guidelines: The beginning of a consensus project. Quality and Safety in Health Care 14:319–325, 2005.PubMedCrossRef
34.
go back to reference Hellerstein DJ, Staub AB, LeQuesne E: Decreasing the use of restraint and seclusion among psychiatric inpatients, Institute on Psychiatric Services, 2006 CME Syllabus and Proceedings Summary, American Psychiatric Association, Arlington VA, 2006, 50. Hellerstein DJ, Staub AB, LeQuesne E: Decreasing the use of restraint and seclusion among psychiatric inpatients, Institute on Psychiatric Services, 2006 CME Syllabus and Proceedings Summary, American Psychiatric Association, Arlington VA, 2006, 50.
35.
go back to reference Hellerstein DJ, Almeida G: Behavioral coping preferences of psychiatric inpatients, New Research Abstracts, Annual Meeting of the American Psychiatric Association, Arlington VA, 2005, 283. Hellerstein DJ, Almeida G: Behavioral coping preferences of psychiatric inpatients, New Research Abstracts, Annual Meeting of the American Psychiatric Association, Arlington VA, 2005, 283.
Metadata
Title
Assessing Obesity and Other Related Health Problems of Mentally Ill Hispanic Patients in an Urban Outpatient Setting
Authors
David J. Hellerstein, M.D.
Goretti Almeida, M.B.A
Michael J. Devlin, M.D.
Nathaniel Mendelsohn, A.B.
Stacia Helfand, M.Ed.
Dianna Dragatsi, M.D.
Raquel Miranda, R.N.
Julie R. Kelso, M.D.
Lucia Capitelli, R.N.
Publication date
01-09-2007
Published in
Psychiatric Quarterly / Issue 3/2007
Print ISSN: 0033-2720
Electronic ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-007-9038-y

Other articles of this Issue 3/2007

Psychiatric Quarterly 3/2007 Go to the issue